AstraZeneca
AZN
#43
Rank
S$402.29 B
Marketcap
S$259.50
Share price
0.36%
Change (1 day)
32.18%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): S$7.03

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$6.77. In 2024 the company made an earnings per share (EPS) of S$5.75 an increase over its 2023 EPS that were of S$4.86.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$7.0322.36%
2024S$5.7518.23%
2023S$4.8681.13%
2022S$2.68631.03%
2021S$0.37-88.11%
2020S$3.09136.89%
2019S$1.30-39.41%
2018S$2.15-28.27%
2017S$3.00-14.37%
2016S$3.5024.11%
2015S$2.82127.55%
2014S$1.24-51.96%
2013S$2.58-58.95%
2012S$6.29-32.2%
2011S$9.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.10 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.32 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.72-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.75-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.15 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.61-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$13.92 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.25 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.76-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.77-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK